Pediatric NASH Study, page-3

I knew there was some information in the October 2018 20-k on enrollment.  Here it is.  First patient enrolled in February 2017.  As of either June 2018 or October 2018 (not sure which, as the filing covers through 6/30 - but the report states "so far randomized over 18 of the targeted 40 patients" ) looks like we had about half the trial enrolled.

I know they mentioned 2nd Q 2019, but somehow I think it's going to be later in the year.  20 more patients to enroll is quite a few.

"We are also currently undergoing a NIH-funded Phase II double blind, placebo control, randomized clinical study of IMM-124E at Emory University, led by Dr. Miriam Vos, who specializes in the treatment of gastrointestinal disease in children as well as fatty liver disease and obesity. The study enrolled its first patient in February 2017 and has so far randomized over 18 of the targeted 40 patients into the study. The top-line results for this study are expected to be reported in 2019."